Investment Stage

Focus Areas

About Investor

Mark Wesson, MPH, FACHE is an investor associated with Network VC and also works as a Venture Partner at Global Health Impact Fund alongside his own consultancy work. He focuses on early-stage deals across healthcare-adjacent deep tech, including biotech/pharma, medical devices, diagnostics, data/analytics, AI, and IoT, and he typically operates around Seed (with Network VC also spanning pre-seed through Series B by mandate). The investment range tied to Network VC is generally described as $25K–$250K per check. Before investing, he built a healthcare-heavy career spanning research and outcomes/quality work, roles with Kaiser Permanente and Stanford Health Care, and later founded Health Care Development Consultancy (HCDC).